THREE ARCH PARTNERS III LP
Insider CIK 1256741 · CNCE 10% owner · ACRX 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACRX ACELRX PHARMACEUTICALS INC | J Other | 2018-05-21 | 2018-05-23 | 126,153 | — | $0 | 0 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | J Other | 2018-05-21 | 2018-05-23 | 3,347,357 | — | $0 | 0 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | J Other | 2018-05-21 | 2018-05-23 | 179,962 | — | $0 | 0 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | J Other | 2018-05-21 | 2018-05-23 | 5,713,569 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2014-11-18 | 2014-11-20 | 237,245 | $12.29 | $2.92M | 540,375 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2014-11-18 | 2014-11-20 | 12,755 | $12.29 | $156.8K | 29,052 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 76,531 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 1,897,959 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 1,423,469 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 20,408 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 102,041 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 379,592 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 13,545 | — | $0 | 14,854 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | P Buy | 2014-02-19 | 2014-02-21 | 98,219 | $14.00 | $1.38M | 777,620 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 18,060 | — | $0 | 32,914 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 251,941 | — | $0 | 276,295 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 335,922 | — | $0 | 612,217 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 67,184 | — | $0 | 679,401 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | P Buy | 2014-02-19 | 2014-02-21 | 5,281 | $14.00 | $73.9K | 41,807 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 3,612 | — | $0 | 36,526 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2012-12-07 | 2012-12-11 | 2,364,705 | $3.31 | $7.83M | 6,323,534 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2012-12-07 | 2012-12-11 | 52,213 | $3.31 | $172.8K | 139,621 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy deriv | 2012-05-29 | 2012-05-31 | 60,789 | $0.13 | $7.9K | 60,789 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy deriv | 2012-05-29 | 2012-05-31 | 3,268 | $0.13 | $425 | 3,268 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy deriv | 2012-05-29 | 2012-05-31 | 188,020 | $0.13 | $24.4K | 188,020 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy deriv | 2012-05-29 | 2012-05-31 | 4,151 | $0.13 | $540 | 4,151 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy deriv | 2012-05-29 | 2012-06-06 | 4,151 | $0.13 | $540 | 4,151 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy deriv | 2012-05-29 | 2012-06-06 | 60,789 | $0.13 | $7.9K | 60,789 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy deriv | 2012-05-29 | 2012-06-06 | 3,268 | $0.13 | $425 | 3,268 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy deriv | 2012-05-29 | 2012-06-06 | 188,020 | $0.13 | $24.4K | 188,020 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2012-05-29 | 2012-05-31 | 67,543 | $3.40 | $229.6K | 3,704,712 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2012-05-29 | 2012-05-31 | 4,613 | $3.40 | $15.7K | 87,408 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2012-05-29 | 2012-05-31 | 208,911 | $3.40 | $710.3K | 3,958,829 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2012-05-29 | 2012-05-31 | 3,631 | $3.40 | $12.3K | 199,174 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2012-05-29 | 2012-06-06 | 208,911 | $3.40 | $710.3K | 3,958,829 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2012-05-29 | 2012-06-06 | 67,543 | $3.40 | $229.6K | 3,704,712 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2012-05-29 | 2012-06-06 | 3,631 | $3.40 | $12.3K | 199,174 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2012-05-29 | 2012-06-06 | 4,613 | $3.40 | $15.7K | 87,408 | SEC↗ |